The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Apoptotic signaling by c-MYC
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis
Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I., & Flavell, R. A. (2006) · Science · doi:10.1126/science.1115035 · Cited by 1,178
c-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Askew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 739
Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell Hybridomas
Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., & Green, D. R. (1992) · Science · doi:10.1126/science.1378649 · Cited by 695
Seoane, J., Le, H.-V., & Massagué, J. (2002) · Nature · doi:10.1038/nature01119 · Cited by 684
Control of c-myc Regulation in Normal and Neoplastic Cells
(1991) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60476-5 · Cited by 618
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Bim is a suppressor of Myc-induced mouse B cell leukemia
Egle, A., Harris, A. W., Bouillet, P., & Cory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401471101 · Cited by 488
RIP1, a kinase on the crossroads of a cell's decision to live or die
Festjens, N., Vanden Berghe, T., Cornelis, S., & Vandenabeele, P. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402085 · Cited by 468
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Myc pathways provoking cell suicide and cancer
Nilsson, J. A., & Cleveland, J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1207261 · Cited by 462
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Hemann, M. T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J. A., Cordon-Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452
Transient excess of MYC activity can elicit genomic instability and tumorigenesis
Felsher, D. W., & Bishop, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3940 · Cited by 419
The RIP kinases: crucial integrators of cellular stress
Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 382
Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis
Annis, M. G., Soucie, E. L., Dlugosz, P. J., Cruz‐Aguado, J. A., Penn, L. Z., Leber, B., & Andrews, D. W. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600675 · Cited by 376
Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced Apoptosis
Hueber, A.-O., Zörnig, M., Lyon, D., Suda, T., Nagata, S., & Evan, G. I. (1997) · Science · doi:10.1126/science.278.5341.1305 · Cited by 370
The role of c-myc in cell growth
Evan, G. I., & Littlewood, T. D. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80339-9 · Cited by 365
Amati, B., & Land, H. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90098-1 · Cited by 362
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest
Ho, J. S. L., Ma, W., Mao, D. Y. L., & Benchimol, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7423-7431.2005 · Cited by 312
NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP
Kreuz, S., Siegmund, D., Rumpf, J.-J., Samel, D., Leverkus, M., Janssen, O., Häcker, G., Dittrich-Breiholz, O., Kracht, M., Scheurich, P., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401036 · Cited by 257
Ricci, M. S., Kim, S.-H., Ogi, K., Plastaras, J. P., Ling, J., Wang, W., Jin, Z., Liu, Y. Y., Dicker, D. T., Chiao, P. J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.006 · Cited by 255
Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity
Ricci, M. S., Jin, Z., Dews, M., Yu, D., Thomas-Tikhonenko, A., Dicker, D. T., & El-Deiry, W. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8541-8555.2004 · Cited by 243
Function and regulation of the transcription factors of the Myc/Max/Mad network
Lüscher, B. (2001) · Gene · doi:10.1016/s0378-1119(01)00697-7 · Cited by 241
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes
Gartel, A. L., & Shchors, K. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00020-4 · Cited by 238
The proto-oncogene c-myc in hematopoietic development and leukemogenesis
Hoffman, B., Amanullah, A., Shafarenko, M., & Liebermann, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205400 · Cited by 228
Self-citationFrançois, S., El Benna, J., Dang, P. M. C., Pedruzzi, E., Gougerot-Pocidalo, M.-A., & Elbim, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3633 · Cited by 227
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis
Eischen, C. M., Woo, D., Roussel, M. F., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5063-5070.2001 · Cited by 214
Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
Mitchell, K., Ricci, M. S., Miyashita, T., Dicker, D. T., Jin, Z., Reed, J. C., & El‐Deiry, W. S. (2000) · PubMed · Cited by 201
Akt Is a Downstream Target of NF-κB
Meng, F., Liu, L., Chin, P. C., & D'Mello, S. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112464200 · Cited by 193
Baudino, T. A., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.691-702.2001 · Cited by 179
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
Pusapati, R. V., Rounbehler, R. J., Hong, S., Powers, J. T., Yan, M., Kiguchi, K., McArthur, M. J., Wong, P. K. Y., & Johnson, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507367103 · Cited by 177
Vairapandi, M., Balliet, A. G., Fornace, A. J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1996) · PubMed · Cited by 175
Self-citationTumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
Nikiforov, M. A., Riblett, M., Tang, W.-H., Gratchouck, V., Zhuang, D., Fernandez, Y., Verhaegen, M., Varambally, S., Chinnaiyan, A. M., Jakubowiak, A. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708380104 · Cited by 173
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
Eischen, C. M., Packham, G., Nip, J., Fee, B. E., Hiebert, S. W., Zambetti, G. P., & Cleveland, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204892 · Cited by 168
The proto-oncogene c-myc and apoptosis
Hoffman, B., & Liebermann, D. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202592 · Cited by 164
Self-citationSynthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Wang, Y., Engels, I. H., Knee, D. A., Nasoff, M., Deveraux, Q. L., & Quon, K. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00113-8 · Cited by 161
The Oscar-worthy role of Myc in apoptosis
Meyer, N., Kim, S. S., & Penn, L. Z. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.011 · Cited by 158
c-Myc Functionally Cooperates with Bax To Induce Apoptosis
Juin, P. P., Hunt, A. E., Littlewood, T. D., Griffiths, B. L., Swigart, L. B., Korsmeyer, S. J., & Evan, G. I. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6158-6169.2002 · Cited by 149
The MAX-interacting transcription factor network
Hurlin, P. J., & Huang, J. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.009 · Cited by 147
Myc Goes Global: New Tricks for an Old Oncogene
Knoepfler, P. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0426 · Cited by 147
c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms.
Sakamuro, D., Eviner, V. T., Elliott, K. J., Showe, L. C., White, E., & Prendergast, G. C. (1995) · PubMed · Cited by 145
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 136
c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-X L
Maclean, K. H., Keller, U. B., Galindo, C. R., Nilsson, J. A., & Cleveland, J. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7256-7270.2003 · Cited by 130
Schulze‐Bergkamen, H., Brenner, D., Krueger, A., Suess, D., Fas, S. C., Frey, C. R., Dax, A., Zink, D., Büchler, P., Müller, M., et al. (2004) · Hepatology · doi:10.1002/hep.20138 · Cited by 120
Conzen, S. D., Gottlob, K., Kandel, E., Khanduri, P., Wagner, A. J., O'Leary, M., & Hay, N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6008-6018.2000 · Cited by 120
Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation
Klefström, J. T., Arighi, E., Littlewood, T., Jäättelä, M., Saksela, E., Evan, G. I., & Alitalo, K. K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7382 · Cited by 117
Lindemans, C. A., Coffer, P. J., Schellens, I. M. M., de Graaff, P. M. A., Kimpen, J. L. L., & Koenderman, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5529 · Cited by 114
The great MYC escape in tumorigenesis
Dang, C. V., O’Donnell, K. A., & Juopperi, T. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.005 · Cited by 111
Cavarretta, I. T. R., Neuwirt, H., Untergasser, G., Moser, P. L., Zaki, M. H., Steiner, H., Rumpold, H. F., Fuchs, D., Hobisch, A., Nemeth, J. A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210097 · Cited by 105
Guillouf, C., Graña, X., Selvakumaran, M., Luca, A. D., Giordano, A., Hoffman‐Liebermann, B., & Liebermann, D. A. (1995) · Blood · doi:10.1182/blood.v85.10.2691.bloodjournal85102691 · Cited by 95
Self-citationTransgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
Adams, J. M., Harris, A. W., Strasser, A., Ogilvy, S., & Cory, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202997 · Cited by 89
Functional analysis of the N-terminal domain of the Myc oncoprotein
Oster, S. K., Mao, D. Y. L., Kennedy, J. L., & Penn, L. Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206228 · Cited by 87
Amundson, S. A., Zhan, Q., Penn, L. Z., & Fornace, A. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202136 · Cited by 87
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
Rottmann, S., & Lüscher, B. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_4 · Cited by 85
Liebermann, D. A., & Hoffman‐Liebermann, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402477 · Cited by 83
Self-citationExpression of Fas Ligand in Activated T Cells Is Regulated by c-Myc
Brunner, T., Kasibhatla, S., Pinkoski, M. J., Frutschi, C., Yoo, N. J., Echeverri, F., Mahboubi, A., & Green, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9767 · Cited by 83
Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.
Hsu, B., Marín, M. C., El‐Naggar, A. K., Stephens, L. C., Brisbay, S. M., & McDonnell, T. J. (1995) · PubMed · Cited by 83
c‐Myc primed mitochondria determine cellular sensitivity to TRAIL‐induced apoptosis
Nieminen, A. I., Partanen, J. I., Hau, A., & Klefström, J. T. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601551 · Cited by 77
Specific Requirement for Bax, Not Bak, in Myc-induced Apoptosis and Tumor Suppression in Vivo
Dansen, T. B., Whitfield, J. R., Rostker, F., Swigart, L. B., & Evan, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513655200 · Cited by 76
ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress
Pauklin, S., Kristjuhan, A., Maimets, T., & Jaks, V. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.097 · Cited by 69
BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis
Patel, J. H., & McMahon, S. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609138200 · Cited by 68
Askew, D. S., Ihle, J., & Cleveland, J. (1993) · Blood · doi:10.1182/blood.v82.7.2079.2079 · Cited by 68
Nieminen, A. I., Partanen, J. I., & Klefström, J. T. (2007) · Cell Cycle · doi:10.4161/cc.6.20.4917 · Cited by 65
c-Myc and Caspase-2 Are Involved in Activating Bax during Cytotoxic Drug-induced Apoptosis
Cao, X., Bennett, R. L., & May, W. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801107200 · Cited by 61
Switching from life to death: The Miz-ing link between Myc and p53
Vousden, K. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00186-1 · Cited by 56
Endogenous bcl-2 is not required for the development of Eμ-myc–induced B-cell lymphoma
Kelly, P. N., Puthalakath, H., Adams, J. M., & Strasser, A. (2007) · Blood · doi:10.1182/blood-2006-10-051847 · Cited by 53
A Myc-Induced Apoptosis Pathway Surfaces
Green, D. R. (1997) · Science · doi:10.1126/science.278.5341.1246 · Cited by 52
A ‘non-canonical’ DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc
Kasibhatla, S., Beere, H. M., Brunner, T., Echeverri, F., & Green, D. R. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00727-2 · Cited by 50
Sargent, L. M., Sanderson, N. D., & Thorgeirsson, S. S. (1996) · PubMed · Cited by 50
Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis
Patel, J. H., & McMahon, S. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m513038200 · Cited by 43
p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation
Amanullah, A., Liebermann, D. A., & Hoffman, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203638 · Cited by 37
Self-citationIaccarino, I., Hancock, D. C., Evan, G. I., & Downward, J. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401211 · Cited by 31
Amanullah, A., Liebermann, D. A., & Hoffman‐Liebermann, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205231 · Cited by 27
Self-citationJiang, X., Tsang, Y. H., & Yu, Q. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.024 · Cited by 25
p14ARF directly interacts with Myc through the Myc BoxII domain
Amente, S., Gargano, B., Varrone, F., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.3.2389 · Cited by 18
The Max network: coordinated transcriptional regulation of cell growth and proliferation.
Eisenman, R. N. (2002) · PubMed · Cited by 18
Vesely, D. L., Hoffman‐Liebermann, B., & Liebermann, D. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210109 · Cited by 14
Self-citationLüscher, B., & Larsson, L. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401121 · Cited by 12
Regulation of Myc function by ARF: Checkpoint for Myc-induced oncogenesis
Sarkar, D., & Fisher, P. B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.6.2939 · Cited by 6
Cited by
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Johnson, N. A., Slack, G. W., Savage, K. J., Connors, J. M., Ben-Neriah, S., Rogic, S., Scott, D. W., Tan, K. L., Steidl, C., Sehn, L. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0985 · Cited by 975
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 818
Genetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
Exploring miRNA based approaches in cancer diagnostics and therapeutics
Mishra, S., Yadav, T., & Rani, V. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.003 · Cited by 493
Metadata
- Authors
- Hoffman, B., & Liebermann, D. A.
- Venue
- Oncogene
- Published
- 2008-10-27
- Volume
- 27
- Issue
- 50
- Pages
- 6462-6472
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2012654383
- Cited by
- 488
- References
- 89
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.